Re: OTC Expert & Grey Market Restrictions
in response to
by
posted on
Nov 22, 2022 02:35PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
I'm not sure either. To me, it reads as a blanket statement but how much or what parts apply just to TD I can't decipher.